Xi Huang

27PUBLICATIONS
44CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersParticle physicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|May 26, 2026
Soluble TREM2 engages cell-surface nucleolin to drive vascular permeability and malignant ascites in ovarian cancer.

|Feb 20, 2026
Engineered nanovesicles as a DC vaccine to enhance the antitumor efficacy of CAR-T cells against solid tumors.

Shaolong Ju, Tianchuan Zhu, Shoudeng Chen

|Aug 04, 2025
Lung metastasis and recurrence is mitigated by CAR macrophages, in-situ-generated from mRNA delivered by small extracellular vesicles.

Yuchen Xiao, Tianchuan Zhu, Zhenxing Chen

|Jul 29, 2025
AR+TREM2+ macrophage induced pathogenic immunosuppression promotes prostate cancer progression.

Qiaohua Wang, Yongjian Wu, Yili Long

|Jul 27, 2025
Platelet membrane-coated nanoparticles inhibit platelet activation and neutrophil extracellular traps formation in acute lung injury.

Xingyu Li, Zhaoxia Tang, Liangjian Kuang

|Apr 10, 2025
Inflammatory CD11c+ B Cells Induced by the TREM2 Signal Accelerate Sepsis Development.

Siqi Ming, Zhenxing Chen, Jingwen Yang

Pageof 5

Frequent Collaborators

4 joint publications

Hong Shan

4 joint publications

Tianchuan Zhu

4 joint publications

Yongjian Wu

3 joint publications

Zhenxing Chen